But, if you read the EUA, it says it cannot be used without Remdesivir! Must be used in combination with it!
Sounds like a way to attempt to force doctors to use Remdesivir if you ask me.
Look at what the WHO has to say about it:
Remdesivir is worthless and per the WHO should NOT be used!
So, Eli Lilly's tie-in of their drug baricitinib with remdesivir may backfire if doctors refuse to use remdesivir.
If you ask me, it shows in the long run, maybe not the short run, that NP's refusal to do any studies of leronlimab in combination with remdesivir may have been the absolute correct decision!